Tariq Arshad - Dec 8, 2021 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
SVP/Chief Medical Officer
Signature
/s/ Hayden Trubitt, Attorney-in-Fact for Tariq Arshad
Stock symbol
QLGN
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 05:15 AM
Previous filing
May 17, 2021
Next filing
Aug 4, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QLGN Stock Option (Right to Buy) Award $0 +300K $0.00 300K Dec 8, 2021 Common Stock 300K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the stock option vest over two-plus years in three equal annual installments from the vesting commencement date of May 17, 2021.